Efficacy and hypoglycaemia outcomes of once‐weekly insulin icodec versus once‐daily basal insulin comparators across baseline <scp>HbA1c</scp> , <scp>BMI</scp> and duration of type 2 diabetes subgroups: A post hoc analysis of <scp>ONWARDS</scp> 1–5
The efficacy and hypoglycaemia profile of icodec versus OD basal insulin comparators was overall consistent across trial populations irrespective of baseline HbA1c, BMI or T2D duration.
Authors
- Alice Cheng (ORCID: https://orcid.org/0000-0003-2729-606X)
- Siri Vinther (ORCID: https://orcid.org/0000-0003-4823-0713)
- Luís Henrique Santos Canani (ORCID: https://orcid.org/0000-0002-1813-4491)
- Gayathri Anil (ORCID: https://orcid.org/0000-0003-4972-1629)
- Ni Wang (ORCID: https://orcid.org/0000-0003-4961-7477)
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Novo Nordisk (Denmark) (DK)
- Trillium Health Centre (CA)
- Hospital de Clínicas de Porto Alegre (BR)
- Novo Nordisk (India) (IN)
- KU Leuven (BE)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1111/dom.70358
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Novo Nordisk